Several clinical studies have found that patients with low circulating IGF-1 levels at admission have a higher mortality rate and are associated with increased stroke scale scores from the National Institute of Health several months after stroke (Bondanelli et al., 2006; De Smedt et al., 2011). This evidence concerns the gene IGF1 and Stroke.